Your browser doesn't support javascript.
loading
Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa.
Brado, Dominik; Obasa, Adetayo Emmanuel; Ikomey, George Mondinde; Cloete, Ruben; Singh, Kamalendra; Engelbrecht, Susan; Neogi, Ujjwal; Jacobs, Graeme Brendon.
Affiliation
  • Brado D; Division of Virology, Institute for Virology and Immunobiology, Faculty of Medicine, University of Wuerzburg, 97080, Wuerzburg, Germany.
  • Obasa AE; Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, 7505, Cape Town, South Africa.
  • Ikomey GM; Division of Medical Virology, Department of Pathology, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, 7505, Cape Town, South Africa. obasa@sun.ac.za.
  • Cloete R; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, University of Stockholm, Stockholm, Sweden. obasa@sun.ac.za.
  • Singh K; CSCCD, Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Yaoundé, Cameroon.
  • Engelbrecht S; South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Western Cape, South Africa.
  • Neogi U; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, University of Stockholm, Stockholm, Sweden.
  • Jacobs GB; Department of Molecular Microbiology and Immunology, Columbia, MO, 65211, USA.
Sci Rep ; 8(1): 4709, 2018 03 16.
Article de En | MEDLINE | ID: mdl-29549274

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Inhibiteurs de l'intégrase du VIH / Intégrase du VIH / Résistance virale aux médicaments / Mutation Type d'étude: Risk_factors_studies Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Sci Rep Année: 2018 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Inhibiteurs de l'intégrase du VIH / Intégrase du VIH / Résistance virale aux médicaments / Mutation Type d'étude: Risk_factors_studies Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Sci Rep Année: 2018 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni